(ENMD) Community Analysis from
Bulls REASONS TO BUY
|
100%
agree
5 votes
|
Solid cash position |
|
100%
agree
3 votes
|
FDA has accepted new drug application for Rheumatoid Arthritis drug |
|
100%
agree
2 votes
|
Strong revenue growth |
Bears REASONS TO SELL
May 24, 2013
EntreMed (ENMD) Company Overview
There is no analysis for ENMD yet. But you can go to Wikinvest to help create one!
